How shorted is Xvivo Perfusion Aktiebolag?
5.33%
of share capital in disclosed short positions · 10 Jul 2026
- 5-day change
- –
- 20-day change
- –
Who is short Xvivo Perfusion Aktiebolag?
| Position holder | Position | Since |
|---|---|---|
| Marchant MC Ltd | 1.57% | 8 May 2026 |
| JPMorgan Asset Management (UK) Ltd | 1.18% | 23 Apr 2026 |
| Citadel Advisors LLC | 0.90% | 9 Jul 2026 |
| D E Shaw Co LP | 0.59% | 21 Apr 2026 |
| Winton Capital Management Limited | 0.59% | 17 Apr 2026 |
| ActusRayPartners Limited | 0.50% | 12 May 2026 |
Named positions of 0.5%+ as published by the Finansinspektionen. The dates shown are each holder's latest disclosure date.
History
| Position date | Short % | Change |
|---|---|---|
| 10 Jul 2026 | 5.33% | – |
Frequently asked questions
- How shorted is Xvivo Perfusion Aktiebolag right now?
- Disclosed net short positions total 5.33% of Xvivo Perfusion Aktiebolag's share capital as of 10 Jul 2026, per the Finansinspektionen's public register.
- Who is shorting Xvivo Perfusion Aktiebolag?
- The Finansinspektionen names each holder of a position of 0.5% or more. Currently disclosed: Marchant MC Ltd, JPMorgan Asset Management (UK) Ltd, Citadel Advisors LLC and 3 more.
- What does this number include?
- The sum of individually disclosed net short positions of 0.5% or more of share capital. Positions between 0.1% and 0.5% are reported to the regulator privately and are not public, so the true total can be higher.
- How often is this updated?
- Position holders must disclose changes by the next trading day; we refresh from the Finansinspektionen's register every trading day.